Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies
A Nombel, N Fabien, F Coutant - Frontiers in immunology, 2021 - frontiersin.org
Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in
Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly …
Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly …
[HTML][HTML] Where are we moving in the classification of idiopathic inflammatory myopathies?
Where are we moving in the classification of idiopathic infl... : Current Opinion in Neurology
Where are we moving in the classification of idiopathic inflammatory myopathies? : Current …
Where are we moving in the classification of idiopathic inflammatory myopathies? : Current …
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
Y Ye, Z Chen, S Jiang, F Jia, T Li, X Lu, J Xue… - Nature …, 2022 - nature.com
Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5+ DM) is
an autoimmune condition associated with rapidly progressive interstitial lung disease and …
an autoimmune condition associated with rapidly progressive interstitial lung disease and …
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry
P Mehta, PM Machado, L Gupta - Rheumatology International, 2021 - Springer
Abstract Anti-Melanoma Differentiation-Associated gene 5 (MDA-5) Dermatomyositis
(MDA5, DM) is a recently identified subtype of myositis characteristically associated with …
(MDA5, DM) is a recently identified subtype of myositis characteristically associated with …
The role of interferons type I, II and III in myositis: A review
L Bolko, W Jiang, N Tawara… - Brain …, 2021 - Wiley Online Library
The classification of idiopathic inflammatory myopathies (IIM) is based on clinical,
serological and histological criteria. The identification of myositis‐specific antibodies has …
serological and histological criteria. The identification of myositis‐specific antibodies has …
Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 …
J So, H So, VTL Wong, R Ho, TY Wu, PCH Wong… - …, 2022 - academic.oup.com
Objective Anti-melanoma differentiation-associated protein 5 (MDA5)-positive DM is
associated with rapidly progressive interstitial lung disease (RP-ILD) and high mortality. This …
associated with rapidly progressive interstitial lung disease (RP-ILD) and high mortality. This …
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review
D Gonzalez, L Gupta, V Murthy, EB Gonzalez… - Rheumatology …, 2022 - Springer
Abstract Anti-MDA5 (Melanoma differentiation-associated protein 5) myositis is a rare
subtype of dermatomyositis (DM) characterized by distinct ulcerative, erythematous …
subtype of dermatomyositis (DM) characterized by distinct ulcerative, erythematous …
Epidemiology of the idiopathic inflammatory myopathies
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic
autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints …
autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints …
Dermatomyositis: muscle pathology according to antibody subtypes
J Tanboon, M Inoue, Y Saito, H Tachimori, S Hayashi… - Neurology, 2022 - AAN Enterprises
Background and Objectives Discoveries of dermatomyositis-specific antibodies (DMSAs) in
patients with dermatomyositis raised awareness of various myopathologic features among …
patients with dermatomyositis raised awareness of various myopathologic features among …